Frank Litvack

CIK 1310715 · CEO and Chairman · last filed 2026-05-14

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$4.65M

Companies

4

Total Filings

24

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
CAPR	Director	180,054	$25.80	$4.65M	$0	18	2026-05-14
CAPRICOR THERAPEUTICS, INC. (NLTXW) Delisted	Director	200,000	—	—	$0	2	2011-05-12
CAPRICOR THERAPEUTICS, INC. (NLTX) Delisted	Director	200,000	$13.96	$2.79M	$0	1	2009-09-28
CONOR MEDSYSTEMS INC (CONR) Delisted	CEO and Chairman	0	—	—	$0	2	2007-02-02

Recent Filings · Page 3 of 3

24 filings

Form 4 transactions across all companies, newest first.

Filed	Symbol	Action	Net Shares	Net $	Link
2010-07-28	CAPRICOR THERAPEUTICS, INC. (NLTXW) Delisted	Grant (A)	—	$0	EDGAR
2009-09-28	CAPRICOR THERAPEUTICS, INC. (NLTX) Delisted	Grant (A)	—	$0	EDGAR
2007-02-02	CONOR MEDSYSTEMS INC (CONR) Delisted	Disp (D)	−398,351	-$13.34M	EDGAR
2007-01-03	CONOR MEDSYSTEMS INC (CONR) Delisted	Mixed	+204,701	$0	EDGAR

Showing 21–24 of 24

Prev Page 3 of 3

Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.